35 results on '"Pedagogos, Eugenie"'
Search Results
2. The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial
3. A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
4. Should nephrologists consider vascular calcification screening?
5. Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease
6. Calcific uraemic arteriolopathy in a patient with end-stage renal failure and chronic plaque psoriasis: could TNF-α inhibition help ameliorate disease progression?
7. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure
8. Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study
9. Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk
10. Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients
11. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice
12. Coronary artery, cerebrovascular and peripheral vascular disease
13. Diabetes
14. Phosphate levels—time for a rethink!
15. Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial
16. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
17. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis
18. Vancomycin dosing in chronic high-flux haemodialysis: a systematic review
19. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study
20. Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial
21. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
22. Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.
23. Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial
24. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
25. Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
26. The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.
27. Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study
28. Factors Associated with Chronic Kidney Disease Progression in Australian Nephrology Practices
29. Increased Iron Requirement in Hemodialysis Patients on Antiplatelet Agents or Warfarin
30. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
31. Differential effects of phosphate binders on predialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis.
32. Reply.
33. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
34. The CARI guidelines. Diabetes.
35. The CARI guidelines. Coronary artery, cerebrovascular and peripheral vascular disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.